Organisation paid for research Program year 2025 Source: CMS Open Payments

Vance Thompson Vision

Neither a doctor nor a teaching hospital

Research payments

$4,523,538

1,211 payments

Through program year 2025, Vance Thompson Vision is reported as receiving $4,523,538 in research payments, across 1,211 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$469,796	75
2024	Research	$519,716	393
2023	Research	$856,976	101
2022	Research	$739,680	134
2021	Research	$957,752	344
2020	Research	$550,439	99
2019	Research	$429,179	65

Breakdown

Who paid Research payments · program years 2019–2025

Alcon Research LLC $2,361,191 1,055 payments
Ocular Therapeutix, Inc. $612,289 17 payments
RxSight Inc $602,801 24 payments
Glaukos Corporation $476,291 95 payments
Oyster Point Pharma, Inc. $194,909 1 payment
Johnson & Johnson Surgical Vision, Inc. $163,600 5 payments
AbbVie, Inc. $107,457 13 payments
Novartis Pharmaceuticals Corporation $5,000 1 payment

Studies the money was for Research payments · program years 2019–2025

RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $581,946 23 payments
Next Generation Cataract Surgery Study $417,508 371 payments
In Clinic Optometrist Insertion of DEXTENZA Prior to Cataract Surgery $353,184 9 payments
User Product Evaluation Protocol $345,043 56 payments
Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes in Conjunction with InnovEyes sightmap $271,982 338 payments
Comparison of the vision and quality of life outcomes following Contoura with Phorcides compared to WaveLight Wavefront optimized LASIK. $240,870 3 payments
A Randomized, Controlled, Double-Masked, Two-Arm Investigator-Initiated Study to Assess the Efficacy of Oc-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease in Subjects Following Laser-Assisted in Situ Keratomileusis (Lasik) $194,909 1 payment
Vivity Outcomes in patients with early stage glaucoma $145,775 3 payments
The RESTORE Study $139,430 2 payments
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study $135,870 15 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.